Incidence, risk factors, and consequences of residual neuromuscular block in the United States: The prospective, observational, multicenter RECITE-US study. Journal of clinical anesthesia Saager, L., Maiese, E. M., Bash, L. D., Meyer, T. A., Minkowitz, H., Groudine, S., Philip, B. K., Tanaka, P., Gan, T. J., Rodriguez-Blanco, Y., Soto, R., Heisel, O. 2018; 55: 33–41

Abstract

STUDY OBJECTIVE: To determine the incidence burden and associated risk factors of residual neuromuscular block (rNMB) during routine U.S. hospital care.DESIGN: Blinded multicenter cohort study.SETTING: Operating and recovery rooms of ten community and academic U.S. hospitals.PATIENTS: Two-hundred fifty-five adults, ASA PS 1-3, underwent elective abdominal surgery with general anesthesia and =1 dose of non-depolarizing neuromuscular blocking agent (NMBA) for endotracheal intubation and/or maintenance of NMB between August 2012 and April 2013.INTERVENTIONS: TOF measurements using acceleromyography were performed on patients already receiving routine anesthetic care for elective open or laparoscopic abdominal surgery. Measurements allowed assessment of the presence of residual neuromuscular block (rNMB), defined as a train-of-four (TOF) ratio <0.9 at tracheal extubation. We recorded patient and procedural characteristics and assessed TOF ratios (T4/T1) at various times throughout the procedure and at tracheal extubation. Differences in patient and clinical characteristics were compared using Fisher's exact test for categorical variables and t-test for continuous variables. Multivariate logistic regression assessed risk factors associated with rNMB at extubation.MAIN RESULTS: Most of the study population, 64.7% (n?=?165) had rNMB (TOF ratio?

View details for PubMedID 30594097